Marek Chawarski, PhD

Associate Professor of Psychiatry and of Emergency Medicine

Contact Information

Marek Chawarski, PhD

Mailing Address

  • Psychiatry

    CMHC/SAC, 34 Park Street

    New Haven, CT, 06519

    United States

Marek Chawarski
DownloadHi-Res Photo

Appointments

Education & Training

  • PhD
    Yale University (1995)
  • MPhil
    Yale University, Psychology (1993)
  • MS
    Yale University, Psychology/Cognitive (1992)
  • MA
    Jagiellonian University, Krakow, Poland, Psychology/Clinical, Cognitive (1987)

Activities

  • Teaching and mentoring
    Changsha, China 2015
    Honorary Guest Professorship
  • Substance abuse treatment
    Wuhan, China (2010-2017)
    A study entitled "Behavioral Drug and HIV Risk Reduction Counseling with MMT in China" will provide critical data regarding the efficacy for reducing drug-and sex-related HIV transmission risk behaviors, as well as improving MMT outcomes and patient functioning of two transportable counseling models, behavioral drug and HIV risk reduction counseling (BDRC) and educational counseling (EC) as compared with the current standard of care model in MMT in China.
  • Teaching and research collaboration
    Taipei, Taiwan 2010
  • Substance abuse treatment
    Saint Petersburg, Russia (2010-2017)
    A study entitled "Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia" will examine the effects of combining behavioral therapy with naltrexone pharmacotherapy for the treatment of opiate dependence and reduction of HIV risks in opiate dependent individuals in St. Petersburg, Russia.
  • Research and training collaboration in substance abuse treatment with Universiti Sains Malaysia
    George Town, Malaysia; Kota Bharu, Malaysia 2010
    Collaborative research and training programs aimed to develop treatments for opiate and amphetamine type stimulants disorders
  • Teaching and mentoring
    George Town, Malaysia 2009
    Adjunct faculty at the Drug Research Centre, University Sains Malaysia (USM)
  • Research and training collaboration
    Jakarta, Indonesia 2009
  • Heroin Dependence
    Tehran, Iran; Muar, Malaysia (2008-2017)
    Professor Schottenfeld has established research projects in Malaysia and Iran which are aimed at evaluating treatments for heroin or other opiate dependence and are comparing the efficacy of maintenance treatment with buprenorphine or naltrexone.
  • Prevention of HIV Infection among Opiate Dependent Injectors - Phase III Randomized Controlled Trial to Evaluate the Efficacy of buprenorphine/naloxone drug treatment in p
    Beijing, China; Chiang Mai, Thailand; Nanning, China; Urumqi, China (2008-2015)
    The purpose of the study is to determine the efficacy of a drug treatment intervention (buprenorphine/naloxone) in the prevention of HIV transmission among opiate dependent injectors by reducing drug use and associated risk behaviors. URL: http://www.hptn.org/research_studies/hptn058.asp

Honors & Recognition

AwardAwarding OrganizationDate
Honorary Guest ProfessorshipCentral South University, Changsha, China2015
International Program Award of Excellence in International Collaborative ResearchNational Institute on Drug Abuse (NIDA)2014
Honorary Guest ProfessorshipCenter for Disease Prevention and Control, Wuhan, China2008

Departments & Organizations